EcoDrugPlus

Platelet Derived Growth Factor Receptor Alpha

Ensembl ID : ENSPLAG00000017781
Gene Symbol: PDGFRA
3 Cross references
203 Possible Orthologues:

Platelet Derived Growth Factor Subunit B

Ensembl ID : ENSPLAG00000003450
Gene Symbol: PDGFB
2 Cross references
190 Possible Orthologues:

Platelet-Derived Growth Factor Receptor Beta-Like

Ensembl ID : ENSPLAG00000018564
Gene Symbol: LOC106939821
3 Cross references
198 Possible Orthologues:

Polo Like Kinase 4

Ensembl ID : ENSPLAG00000011343
Gene Symbol: PLK4
3 Cross references
215 Possible Orthologues:

Poly [Adp-Ribose] Polymerase 2-Like

Ensembl ID : ENSPLAG00000018418
Gene Symbol: LOC106941517
3 Cross references
185 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 1

Ensembl ID : ENSPLAG00000000909
Gene Symbol: PARP1
3 Cross references
209 Possible Orthologues:

Poly(Adp-Ribose) Polymerase Family Member 3

Ensembl ID : ENSPLAG00000014500
Gene Symbol: PARP3
3 Cross references
197 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSPLAG00000023438
Gene Symbol: PORCN
3 Cross references
193 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily M Alpha 1

Ensembl ID : ENSPLAG00000018691
Gene Symbol: KCNMA1
4 Cross references
239 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily M Alpha 1

Ensembl ID : ENSPLAG00000023185
Gene Symbol: KCNMA1
3 Cross references
235 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily N Member 4

Ensembl ID : ENSPLAG00000007549
Gene Symbol: KCNN4
3 Cross references
187 Possible Orthologues:

Potassium Inwardly Rectifying Channel Subfamily J Member 11

Ensembl ID : ENSPLAG00000005563
Gene Symbol: KCNJ11
1 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).